-
-
DNA Electronics partners with Roche to develop semiconductor based sequencing system
DNA Electronics, a fabless semiconductor provider of solutions for real-time DNA and RNA analysis, announced today that it has entered a partnership with 454 Life Sciences, a Roche Company. The collaboration will focus on the development of a low-cost, high-throughput, long read, high density DNA sequencing system. As part of the agreement, DNA Electronics has signed a non-exclusive licence to provide relevant IP from its proprietary semiconductor technology portfolio to Roche. This technology which enables sensitive detection of nucleotide incorporation during sequencing will build on 454 Life Sciences’ current pyrosequencing-based platform. The collaboration leverages DNA Electronics’ unique knowledge of semiconductor design and expertise in pH-mediated detection of nucleotide insertions with 454 Life Sciences’ long read sequencing chemistry to produce a seamless evolution from optical detection to low-cost, highly scalable electrochemical detection.
pdf of press release: http://www.dnae.co.uk/images/2010-11...%20License.pdf -
And it will be called "Ion Current"?...Comment
-
This was pretty interesting to me also...especially since DNA Electronics licensed their tech to Ion Torrent as well.
Maybe we're heading for a big IP battle! Exciting...Comment
-
Exciting indeed eco
I think the next 2 years is going to be great viewing for the impartial observer - and this site will probably give a pretty good front row seat!Comment
-
Sample prep for ISFETs
I wonder if emPCR IP for sample prep will also fall into the fray. All the ISFET sensor tech will need a bead in a well for measurement until solid state nanopores come along.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment